Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2020, titled "Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex�� (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market.".
Press Release Aug 11 2020
Filed with NSE · · 2 pages · English
Release
Dr. Reddy's Laboratories Ltd. on 6ix
Later from Dr. Reddy's Laboratories
- Press Release Aug 19 2020
- Press Release Aug 27 2020
- Press Release Sep 03 2020
- Press Release Sep 07 2020
- Press Release Sep 09 2020
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories